Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer

International Journal of Colorectal Disease

Volumn 28, Issue 4, 2013, Pages 527-535

  Kawai, Kazushige ^a   Kitayama, Joji ^a   Tsuno, Nelson H ^a   Sunami, Eiji ^a   Watanabe, Toshiaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemoradiotherapy; Platelet; Prognosis; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HEMOGLOBIN; UFT;

ADULT; ARTICLE; BARIUM ENEMA; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; CONTINUOUS INFUSION; DISTANT METASTASIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOSIS; TREATMENT RESPONSE; TUMOR INVASION; TUMOR REGRESSION; TUMOR VOLUME;

CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PLATELET COUNT; PREOPERATIVE CARE; RECTAL NEOPLASMS; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 84877876407     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1594-4     Document Type: Article

References (47)

1. Piccioli A, Lensing AW, Prins MH, Falanga A, Scannapieco GL, Ieran M et al (2004) Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2(6):884-889
2. Komurcuoglu B, Ulusoy S, Gayaf M, Guler A, Ozden E (2011) Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori 97(6):743-748
3. Kilic M, Yoldas O, Keskek M, Ertan T, Tez M, Gocmen E et al (2008) Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis Off J Assoc Coloproctology G B Irel 10(3):238-241
4. Morii T, Mochizuki K, Tajima T, Ichimura S, Satomi K (2011) D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma. BMC Musculoskelet Disord 12:250
5. Kwon HC, Oh SY, Lee S, Kim SH, Han JY, Koh RY et al (2008) Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Jpn J Clin Oncol 38(1):2-7
6. Yamashita H, Kitayama J, Kanno N, Yatomi Y, Nagawa H (2006) Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 6:147
7. Yamashita H, Kitayama J, Nagawa H (2005) Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol 35(10):595-600
8. Yamashita H, Kitayama J, Taguri M, Nagawa H (2009) Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg 33(6):1298-1305
9. Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J (2012) Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg 36(1):192-200
10. Kvolik S, Jukic M, Matijevic M, Marjanovic K, Glavas-Obrovac L (2010) An overview of coagulation disorders in cancer patients. Surg Oncol 19(1):e33-e46
11. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11):1114-1123
12. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731-1740
13. Watanabe T, Nagawa H (2004) Sphincter preservation in locally advanced rectal cancer due to the addition of continuous infusion 5-FU to preoperative radiation therapy or advances in surgical techniques? Int J Radiat Oncol Biol Phys 59(2):618, author reply
14. Fu CG, Tominaga O, Nagawa H, Nita ME, Masaki T, Ishimaru G et al (1998) Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 41(1):68-74
15. Kuremsky JG, Tepper JE, McLeod HL (2009) Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 74(3):673-688
16. Marquardt F, Rodel F, Capalbo G, Weiss C, Rodel C (2009) Molecular targeted treatment and radiation therapy for rectal cancer. Strahlenther Onkol 185(6):371-378
17. Kikuchi M, Mikami T, Sato T, Tokuyama W, Araki K, Watanabe M et al (2009) High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. Br J Cancer 101(1):116-123
18. Komuro Y, Watanabe T, Hosoi Y, Matsumoto Y, Nakagawa K, Tsuno N et al (2002) The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer 95(6):1199-1205
19. Komuro Y, Watanabe T, Tsurita G, Muto T, Nagawa H (2005) Evaluating the combination of molecular prognostic factors in tumor radiosensitivity in rectal cancer. Hepatogastroenterology 52(63):666-671
20. Komuro Y, Watanabe T, Tsurita G, Muto T, Nagawa H (2005) Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival. Hepatogastroenterology 52(64):985-989
21. Watanabe T, Komuro Y, Kiyomatsu T, Kanazawa T, Kazama Y, Tanaka J et al (2006) Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 66(7):3370-3374
22. Kawai K, Kitayama J, Tsuno NH, Sunami E, Nagawa H (2011) Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer. Int J Color Dis 26(1):45-51
23. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228-247
24. Suzuki T, Sadahiro S, Fukasawa M, Ishikawa K, Kamijo A, Yasuda S et al (2004) Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer. Jpn J Clin Oncol 34(12):740-746
25. Sadahiro S, Suzuki T, Maeda Y, Tanaka Y, Nakamura T, Saguchi T et al (2007) Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma. Hepato-Gastroenterology 54(76):1107-1112
26. Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12(1):19-23
27. Hoff CM (2012) Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol 51(4):419-432
28. Jain S, Harris J, Ware J (2010) Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol 30(12):2362-2367
29. Hwang SG, Kim KM, Cheong JH, Kim HI, An JY, Hyung WJ, et al (2012) Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer. Eur J Surg Oncol 38(7):562-7
30. Cakar B, Karaoglanoglu M, Sayici Y, Gonullu Demirag G, Yucel I (2011) The prognostic value of thrombocytosis in newly diagnosed lung cancer patients: a retrospective analysis. J Buon 16(4):677-81
31. Metindir J, Bilir Dilek G (2009) Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. J Cancer Res Clin Oncol 135(1):125-129
32. Aminian A, Karimian F, Mirsharifi R, Alibakhshi A, Dashti H, Jahangiri Y et al (2011) Significance of platelet count in esophageal carcinomas. Saudi J Gastroenterol 17(2):134-137
33. Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J et al (2002) Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30(5):450-459
34. Dashevsky O, Varon D, Brill A (2009) Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer 124(8):1773-1777
35. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A 98(6):3352-3357
36. Trikha M, Zhou Z, Timar J, Raso E, Kennel M, Emmell E et al (2002) Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 62(10):2824-2833
37. Karpatkin S, Pearlstein E, Ambrogio C, Coller BS (1988) Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81(4):1012-1019
38. Nieswandt B, Hafner M, Echtenacher B, Mannel DN (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295-1300
39. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S et al (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111(3):1227-1233
40. Pyne S, Pyne NJ (2000) Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349(Pt 2):385-402
41. Tanikawa T, Kurohane K, Imai Y (2010) Regulatory effect of lysophosphatidic acid on lymphocyte migration. Biol Pharm Bull 33(2):204-208
42. Mori K, Kitayama J, Shida D, Yamashita H, Watanabe T, Nagawa H (2006) Lysophosphatidic acid-induced effects in human colon carcinoma DLD1 cells are partially dependent on transactivation of epidermal growth factor receptor. J Surg Res 132(1):56-61
43. Shida D, Fang X, Kordula T, Takabe K, Lepine S, Alvarez SE et al (2008) Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res 68(16):6569-6577
44. Shida D, Kitayama J, Yamaguchi H, Okaji Y, Tsuno NH, Watanabe T et al (2003) Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 63(7):1706-1711
45. Shida D, Kitayama J, Yamaguchi H, Yamashita H, Mori K, Watanabe T et al (2005) Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. World J Gastroenterol: WJG 11(36):5638-5643
46. Chi H (2011) Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol Sci 32(1):16-24
47. Weigert A, Weis N, Brune B (2009) Regulation of macrophage function by sphingosine-1-phosphate. Immunobiology 214(9-10):748-760